How to Design a Non-Inferiority Margin for NAD+...

A meta-analytic method sets a defensible non-inferiority margin for NAD+ precursors versus Vesugen in cognitive decline trials by pooling effect sizes and

Designing a Non-Inferiority Trial for Vesugen v...

Learn how to design a non-inferiority trial comparing Vesugen and Cerebrolysin for cognitive outcomes in older adults, focusing on statistical power, assay